SK75296A3 - N-£(1,4-DIAZABICYCLO£2.2.2|OCT-2-YL) METHYL|BENZAMIDE DERIVATIVE, PROCESS FOR PREPARATION THEREOF, THIS DERIVATIVE AS A DRUG AND PHARMACEUTICAL COMPOSITION CONTAINING THIS DERIVATIVEì - Google Patents

N-£(1,4-DIAZABICYCLO£2.2.2|OCT-2-YL) METHYL|BENZAMIDE DERIVATIVE, PROCESS FOR PREPARATION THEREOF, THIS DERIVATIVE AS A DRUG AND PHARMACEUTICAL COMPOSITION CONTAINING THIS DERIVATIVEì Download PDF

Info

Publication number
SK75296A3
SK75296A3 SK752-96A SK75296A SK75296A3 SK 75296 A3 SK75296 A3 SK 75296A3 SK 75296 A SK75296 A SK 75296A SK 75296 A3 SK75296 A3 SK 75296A3
Authority
SK
Slovakia
Prior art keywords
compound
methyl
diazabicyclo
oct
formula
Prior art date
Application number
SK752-96A
Other languages
English (en)
Slovak (sk)
Inventor
Samir Jegham
Jean Jacques Koenig
Alistair Lochead
Alain Nedelec
Yves Guminski
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of SK75296A3 publication Critical patent/SK75296A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D245/00Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/02Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK752-96A 1995-06-13 1996-06-12 N-£(1,4-DIAZABICYCLO£2.2.2|OCT-2-YL) METHYL|BENZAMIDE DERIVATIVE, PROCESS FOR PREPARATION THEREOF, THIS DERIVATIVE AS A DRUG AND PHARMACEUTICAL COMPOSITION CONTAINING THIS DERIVATIVEì SK75296A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9506951A FR2735475B1 (fr) 1995-06-13 1995-06-13 Derives de n-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
SK75296A3 true SK75296A3 (en) 1997-05-07

Family

ID=9479885

Family Applications (1)

Application Number Title Priority Date Filing Date
SK752-96A SK75296A3 (en) 1995-06-13 1996-06-12 N-£(1,4-DIAZABICYCLO£2.2.2|OCT-2-YL) METHYL|BENZAMIDE DERIVATIVE, PROCESS FOR PREPARATION THEREOF, THIS DERIVATIVE AS A DRUG AND PHARMACEUTICAL COMPOSITION CONTAINING THIS DERIVATIVEì

Country Status (19)

Country Link
US (1) US5663173A (hu)
EP (1) EP0748807A1 (hu)
JP (1) JPH09118680A (hu)
KR (1) KR970001335A (hu)
CN (1) CN1143644A (hu)
AR (1) AR004669A1 (hu)
AU (1) AU704388B2 (hu)
CA (1) CA2178849A1 (hu)
CO (1) CO4700470A1 (hu)
CZ (1) CZ171696A3 (hu)
FR (1) FR2735475B1 (hu)
HU (1) HUP9601620A3 (hu)
IL (1) IL118644A (hu)
NO (1) NO305251B1 (hu)
NZ (1) NZ286805A (hu)
PL (1) PL314745A1 (hu)
SK (1) SK75296A3 (hu)
TW (1) TW372238B (hu)
ZA (1) ZA964985B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756564B1 (fr) * 1996-12-04 2004-05-14 Synthelabo Derives d'acide quinoleine-8-carboxylique, leur preparation et leur application en therapeutique
FR2756563B1 (fr) * 1996-12-04 1998-12-24 Synthelabo Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
KR100619639B1 (ko) * 1997-11-07 2006-09-06 파마시아 앤드 업존 캄파니 엘엘씨 옥사졸리디논의 제조 방법
JP2002518352A (ja) * 1998-06-15 2002-06-25 セプラコア インコーポレーテッド 無呼吸、過食症およびその他の障害を治療するための光学的に純粋な(+)−ノルシスアプリドの使用
EP1468685A3 (en) * 1998-06-15 2004-12-15 Sepracor Inc. Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
ES2237117T3 (es) 1998-06-15 2005-07-16 Sepracor Inc. Uso de (-)norcisaprida opticamente pura en el tratamiento del sindrome del intestino irritable.
EP1464333A3 (en) * 1998-06-15 2004-12-15 Sepracor Inc. Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
WO2005118537A2 (en) * 2004-05-31 2005-12-15 Ranbaxy Laboratories Limited Arylpiperazine derivatives as adrenergic receptor antagonists
US8071605B2 (en) 2008-12-12 2011-12-06 Astrazeneca Ab Piperidine compounds for use in the treatment of bacterial infections
JP5549847B2 (ja) * 2009-11-16 2014-07-16 東ソー株式会社 N−(2−アルコキシメチル)トリエチレンジアミン類の製造法
GB201219820D0 (en) 2012-11-05 2012-12-19 Isis Innovation Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
ES2135414T3 (es) * 1991-09-12 1999-11-01 Smithkline Beecham Plc Antagonistas del receptor 5-ht4.
TW282460B (hu) * 1993-12-28 1996-08-01 Yamanouchi Pharma Co Ltd

Also Published As

Publication number Publication date
CO4700470A1 (es) 1998-12-29
US5663173A (en) 1997-09-02
MX9602306A (es) 1997-10-31
HUP9601620A3 (en) 1998-07-28
EP0748807A1 (fr) 1996-12-18
CA2178849A1 (en) 1996-12-14
NZ286805A (en) 1998-03-25
IL118644A (en) 2000-02-17
IL118644A0 (en) 1996-10-16
JPH09118680A (ja) 1997-05-06
CN1143644A (zh) 1997-02-26
PL314745A1 (en) 1996-12-23
ZA964985B (en) 1997-01-23
FR2735475A1 (fr) 1996-12-20
AU704388B2 (en) 1999-04-22
KR970001335A (ko) 1997-01-24
FR2735475B1 (fr) 1997-07-11
HUP9601620A2 (en) 1997-01-28
CZ171696A3 (en) 1997-01-15
NO962477D0 (no) 1996-06-12
NO305251B1 (no) 1999-04-26
AU5591296A (en) 1997-01-02
NO962477L (no) 1996-12-16
TW372238B (en) 1999-10-21
AR004669A1 (es) 1999-03-10
HU9601620D0 (en) 1996-08-28

Similar Documents

Publication Publication Date Title
FI106552B (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsyyliaminojohdannaisten valmistamiseksi
RU2346945C2 (ru) Производные n-гетероциклилметилбензамидов, их получение и их применение в терапии
US5929089A (en) 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one derivatives for use as 5-Ht4 or H3 receptor ligands
PT584903E (pt) Processo para preparar compostos arilpiperazinil-heterociclicos
PL183933B1 (pl) Związki spiroazabicyklo, sposób wytwarzania związku spiroazabicyklo i kompozycja farmaceutyczna
SK75296A3 (en) N-£(1,4-DIAZABICYCLO£2.2.2|OCT-2-YL) METHYL|BENZAMIDE DERIVATIVE, PROCESS FOR PREPARATION THEREOF, THIS DERIVATIVE AS A DRUG AND PHARMACEUTICAL COMPOSITION CONTAINING THIS DERIVATIVEì
JPH05140149A (ja) 縮合複素環誘導体
US7001902B2 (en) 4-(2 phenylthiazol-5-yl)-1, 4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof
JPH07179466A (ja) イミダゾール−4−イルピペリジン誘導体、それらの製法と医薬への応用
NZ225706A (en) 2-((4-piperidyl)methyl)-1,2,3,4-tetrahydro-9h-pyrido(3,4-b) indole derivatives and their preparation
RU2361873C2 (ru) Производные 1,4-диазабицикло[3.2.1]октанкарбоксамида, их получение и применение в терапии
WO2004043960A1 (en) 1,4-diazabicyclo (3,2,2)nonane derivatives, preparation and therapeutical use thereof
SK34196A3 (en) Piperidine derivatives, preparation method thereof, piperidine derivatives as medicaments and pharmaceutical compositions containing these derivatives
JP2006516653A (ja) キナーゼ阻害剤ピロロトリアジンの製造方法
US4933445A (en) Heteroazabenzobicyclic carboxamide 5-HT3 antagonists
SK74199A3 (en) 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application
JPH06192257A (ja) ピラゾロ〔4,3−c〕ピリジン類、それらの製造方法およびセロトニン再取込み阻害剤としてのそれらの使用
JPH06211838A (ja) ピペリジン誘導体、その製造法および治療への応用
TW200817322A (en) Compounds having activity at the GlyT1 transporter
CS248020B2 (en) Production method of the (+)-enantiomere or (+-)-racemical 4a,9b-trans-hexahydro-1h-pyridoindole derivatives
IE921696A1 (en) Novel azabicyclobenzisoquinolines
WO1999038864A1 (en) Oxazole derivatives as serotonin-1a receptor agonists
JPS6335573A (ja) 新規置換ピリド〔2,3−b〕〔1,4〕ベンゾジアゼピン−6−オン,その製法及びその化合物を含む医薬
US6057340A (en) Oxazole derivatives as serotonin-1A receptor agonists
HUT61301A (en) Process for producing condensed diazepinone derivatives and pharmaceutical compositions comprising same as active ingredient